Introduction
Leading Global Trends: Innovative Strategies and Translational Deployment in Immunomedicine
In response to the rapid advancement of immunomedicine worldwide, our institute strategically focuses on three core pillars: basic research, translational medicine, and drug development.
By integrating cutting-edge technological platforms, robust clinical resources, and an extensive international collaboration network, we are dedicated to building an exceptional environment that brings together advanced technologies, diverse research domains, global connectivity, clinical integration, and academia–industry applications.
Through the organic integration of interdisciplinary resources, we not only foster original and innovative research but also commit to cultivating globally competitive, cross-disciplinary talent. Our mission is to accelerate the translation of scientific discoveries into clinical applications, ultimately generating tangible contributions to industry and society.
Robust Research Strength: Comprehensive Advanced Platforms and Clinical Integration
To realize our forward-looking strategy, the institute has established a high-performance research and training infrastructure. We are equipped with state-of-the-art full-spectrum flow cytometry systems, nanomedicine encapsulation platforms, and P2 laboratories, providing strong technical support for advanced research.
In close collaboration with the Chang Gung Medical System, we leverage abundant clinical data and biospecimen resources to seamlessly bridge basic research and clinical applications.
Our full-time faculty demonstrate world-class academic excellence, with research findings frequently published in leading journals such as Nature Medicine, Nature Metabolism, JAMA, Science Immunology, and the Journal of Experimental Medicine.
In addition, through successful technology transfer and academia–industry collaborations, we have received multiple prestigious national awards. We maintain strong international partnerships with top institutions in the United States, Switzerland, and France, creating a globally connected research environment for students and researchers.
Key Features
- Advanced Research Facilities and Technologies: Equipped with full-spectrum flow cytometers, flow cytometry systems, nanomedicine encapsulation platforms, and P2 laboratories, along with extensive clinical sample resources to support high-impact research.
- Diverse Research Areas: Focused on cutting-edge immunology, including infectious immunity, cancer immunology, and autoimmune diseases, integrated with translational and clinical research.
- International Collaboration: Active partnerships with leading global institutions, including the University of Lausanne (Switzerland) and research organizations in the United States and France, fostering academic exchange and global engagement.
- Clinical Resource Support: Close proximity and collaboration with the Chang Gung Medical System provide rich clinical data and research environments, enabling strong integration between academia and clinical practice.
- Academia–Industry Collaboration and Drug Development: Dedicated to immunotherapeutic development, particularly in immune cell therapies and mRNA-based immunotherapies, promoting real-world application of research outcomes.
- Distinguished Faculty Achievements: Faculty members publish extensively in top-tier journals such as Nature Medicine, JAMA, and Science Immunology, while actively advancing technology transfer and industry collaboration.
- Flexible Curriculum Design: Diverse learning approaches designed to strengthen professional expertise and interdisciplinary integration.
- Student Scholarships: A dedicated annual scholarship of NTD 192,000 is provided to support students in their academic and research endeavors.